Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

123 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus.
Pratley RE, Weyer C. Pratley RE, et al. Among authors: weyer c. Diabetologia. 2001 Aug;44(8):929-45. doi: 10.1007/s001250100580. Diabetologia. 2001. PMID: 11484070 Review.
Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in Type 1 diabetes mellitus: a 1-year, randomized controlled trial.
Ratner RE, Dickey R, Fineman M, Maggs DG, Shen L, Strobel SA, Weyer C, Kolterman OG. Ratner RE, et al. Among authors: weyer c. Diabet Med. 2004 Nov;21(11):1204-12. doi: 10.1111/j.1464-5491.2004.01319.x. Diabet Med. 2004. PMID: 15498087 Clinical Trial.
Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes.
Chapman I, Parker B, Doran S, Feinle-Bisset C, Wishart J, Strobel S, Wang Y, Burns C, Lush C, Weyer C, Horowitz M. Chapman I, et al. Among authors: weyer c. Diabetologia. 2005 May;48(5):838-48. doi: 10.1007/s00125-005-1732-4. Epub 2005 Apr 21. Diabetologia. 2005. PMID: 15843914 Clinical Trial.
AIMS/HYPOTHESIS: Long-term trials in insulin-treated subjects with type 2 diabetes have shown that adjunctive treatment with the amylin analogue pramlintide reduces HbA(1)c levels and elicits weight loss. ...
AIMS/HYPOTHESIS: Long-term trials in insulin-treated subjects with type 2 diabetes have shown that adjunctive treatment with the amylin anal …
The human amylin analog, pramlintide, reduces postprandial hyperglucagonemia in patients with type 2 diabetes mellitus.
Fineman M, Weyer C, Maggs DG, Strobel S, Kolterman OG. Fineman M, et al. Among authors: weyer c. Horm Metab Res. 2002 Sep;34(9):504-8. doi: 10.1055/s-2002-34790. Horm Metab Res. 2002. PMID: 12384827 Clinical Trial.
Unresolved challenges with insulin therapy in type 1 and type 2 diabetes: potential benefit of replacing amylin, a second beta-cell hormone.
Edelman SV, Weyer C. Edelman SV, et al. Among authors: weyer c. Diabetes Technol Ther. 2002;4(2):175-89. doi: 10.1089/15209150260007390. Diabetes Technol Ther. 2002. PMID: 12079621 Review.
Amylin replacement with pramlintide as an adjunct to insulin therapy in type 1 and type 2 diabetes mellitus: a physiological approach toward improved metabolic control.
Weyer C, Maggs DG, Young AA, Kolterman OG. Weyer C, et al. Curr Pharm Des. 2001 Sep;7(14):1353-73. doi: 10.2174/1381612013397357. Curr Pharm Des. 2001. PMID: 11472273 Review.
Long-term clinical studies have consistently demonstrated that pre-prandial s.c. injections of pramlintide, in addition to the current insulin regimen, reduce HbA(1c) and body weight in type 1 and type 2 diabetic patients, without an increase in insulin use or in the event …
Long-term clinical studies have consistently demonstrated that pre-prandial s.c. injections of pramlintide, in addition to the curren …
Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia.
Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA. Weyer C, et al. J Clin Endocrinol Metab. 2001 May;86(5):1930-5. doi: 10.1210/jcem.86.5.7463. J Clin Endocrinol Metab. 2001. PMID: 11344187
Long-term changes in insulin action and insulin secretion associated with gain, loss, regain and maintenance of body weight.
Weyer C, Hanson K, Bogardus C, Pratley RE. Weyer C, et al. Diabetologia. 2000 Jan;43(1):36-46. doi: 10.1007/s001250050005. Diabetologia. 2000. PMID: 10663214
Measurement of insulin sensitivity: influence of potassium supply during euglycaemic glucose clamps in healthy volunteers.
Rave K, Heise T, Weyer C, Sawicki P, Heinemann L. Rave K, et al. Among authors: weyer c. Exp Clin Endocrinol Diabetes. 1999;107(5):313-7. doi: 10.1055/s-0029-1212118. Exp Clin Endocrinol Diabetes. 1999. PMID: 10482044 Clinical Trial.
Influence of continuous combined estradiol-norethisterone acetate preparations on insulin sensitivity in postmenopausal nondiabetic women.
Kimmerle R, Heinemann L, Heise T, Bender R, Weyer C, Hirschberger S, Berger M. Kimmerle R, et al. Among authors: weyer c. Menopause. 1999 Spring;6(1):36-42. Menopause. 1999. PMID: 10100178 Clinical Trial.
Fasting plasma glucose, fasting serum insulin, and C-peptide, as well as triglycerides and BMI were comparable among the groups at baseline and after 3 months. ...
Fasting plasma glucose, fasting serum insulin, and C-peptide, as well as triglycerides and BMI were comparable among the groups at ba …
123 results
Jump to page
Feedback